Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1[Bortezomib Accord]
(D03150)		[1] Bortezomib[1] Bortezomib (D03150) 💬 [1] PSMB5 💬 [8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 28 💬
2BORTEZOMIB
(D03150)		[1] Bortezomib[1] Bortezomib (D03150) 💬 [1] PSMB5 💬 [8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[19] 11, 13, 26, 28, 46, 49, 51, 61, 63, 64, 66, 172, 222, 223, 228, 256, 283, 288, 331 💬
3Bortezomib (drug)
(D03150)		[1] Bortezomib[1] Bortezomib (D03150) 💬 [1] PSMB5 💬 [8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 28 💬
4Bortezomib (Velcade®)
(D03150)		[1] Bortezomib[1] Bortezomib (D03150) 💬 [1] PSMB5 💬 [8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 66 💬
5Bortezomib Accord
(D03150)		[1] Bortezomib[1] Bortezomib (D03150) 💬 [1] PSMB5 💬 [8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 28 💬
6Bortezomib D-mannitol
(D03150)		[3] Bortezomib,
Bortezomib D-mannitol,
Mannitol		[2] Mannitol ,
Bortezomib (D03150) 💬 		[1] PSMB5 💬 [8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 28 💬
7Bortezomib Injection
(D03150)		[1] Bortezomib[1] Bortezomib (D03150) 💬 [1] PSMB5 💬 [8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 64 💬
8Bortezomib+Dexamethasone/Bortezomib+Dexamethasone+Daratumumab/single Daratumumab
(D03150)		[3] Bortezomib,
Daratumumab,
Dexamethasone		[5] Dexamethasone ,
Dexamethasone sodium phosphate ,
Bortezomib (D03150),
Dexamethasone phosphate ,
Daratumumab 💬 		[3] CD38,
NR3C1,
PSMB5 💬 		[15] Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Hematopoietic cell lineage, Huntington disease, Neuroactive ligand-receptor interaction, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Salivary secretion, Spinocerebellar ataxia 💬[1] 28 💬
9Bortezomib/dexamethasone
(D03150)		[2] Bortezomib,
Dexamethasone		[4] Dexamethasone ,
Dexamethasone sodium phosphate ,
Bortezomib (D03150),
Dexamethasone phosphate 💬 		[2] NR3C1,
PSMB5 💬 		[9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 283 💬
10Bortezomib/Dexamethasone (BD), Followed By Autologous STC & Maintenance Bortezomib/Dexamethasone
(D03150)		[2] Bortezomib,
Dexamethasone		[4] Dexamethasone ,
Dexamethasone sodium phosphate ,
Bortezomib (D03150),
Dexamethasone phosphate 💬 		[2] NR3C1,
PSMB5 💬 		[9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 28 💬
11Combination of a single dose anti-CD20 antibody and bortezomib
(D03150)		[1] Bortezomib[1] Bortezomib (D03150) 💬 [1] PSMB5 💬 [8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 61 💬
12Cyclophosphamide, bortezomib, and Dexamethasone (CyBorD) regimen
(D03150)		[3] Bortezomib,
Cyclophosphamide,
Dexamethasone		[6] Cyclophosphamide ,
Dexamethasone ,
Dexamethasone sodium phosphate ,
Bortezomib (D03150),
Cyclophosphamide ,
Dexamethasone phosphate 💬 		[2] NR3C1,
PSMB5 💬 		[9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 28 💬
13Live Combined Bacillus Subtilis and Enterococcus Faecium Enteric-coated Capsules combined with Bortezomib+Dexamethasone/Bortezomib+Dexamethasone+Daratumumab/single Daratumumab
(D03150)		[5] Bacillus subtilis,
Bortezomib,
Daratumumab,
Dexamethasone,
Enterococcus faecium		[5] Dexamethasone ,
Dexamethasone sodium phosphate ,
Bortezomib (D03150),
Dexamethasone phosphate ,
Daratumumab 💬 		[3] CD38,
NR3C1,
PSMB5 💬 		[15] Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Hematopoietic cell lineage, Huntington disease, Neuroactive ligand-receptor interaction, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Salivary secretion, Spinocerebellar ataxia 💬[1] 28 💬
14SoC: cyclophosphamide, bortezomib, and Dexamethasone (CyBorD)
(D03150)		[3] Bortezomib,
Cyclophosphamide,
Dexamethasone		[6] Cyclophosphamide ,
Dexamethasone ,
Dexamethasone sodium phosphate ,
Bortezomib (D03150),
Cyclophosphamide ,
Dexamethasone phosphate 💬 		[2] NR3C1,
PSMB5 💬 		[9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 28 💬